Maxbon™

Ibandronic acid
Bisphosphonate Preparations (Antiosteoporotic Preparations)

Indication:

Maxbon™ Tablet is indicated for:

• Treatment and prevention of postmenopausal osteoporosis in women
• Treatment and prevention of osteoporosis in men

Dosage & Administration:

The recommended dose for the treatment and prevention of osteoporosis is 150 mg tablet once in a month and on the same date of each month is recommended.

Preparation:

Maxbon™ Tablet: Each box contains 1 film coated tablet in Alu-Alu blister pack.